Description
Keytruda Pembrolizumab 50mg Injection: Uses, Side Effects, and Precautions
Keytruda Pembrolizumab 50mg Injection is an immune checkpoint inhibitor used to treat various cancers, including melanoma, lung cancer, and certain head and neck cancers. It works by blocking the PD-1 protein, enabling the immune system to attack cancer cells more effectively.
Dosage and Administration
- Administered under medical supervision via intravenous infusion.
- Typically given every few weeks based on the type of cancer and patient condition.
Common Side Effects
- Fatigue
- Nausea
- Diarrhea
- Rash
- Loss of appetite
Serious Side Effects
Seek immediate medical attention if you experience:
- Persistent cough or breathing difficulties (lung-related reactions)
- Yellowing of the skin or eyes (liver issues)
- Severe diarrhea or abdominal pain (intestinal inflammation)
Precautions and Warnings
- Inform your doctor about any autoimmune diseases or organ transplants.
- Not recommended during pregnancy or breastfeeding.
- Regular monitoring is required to detect potential adverse reactions early.
Disclaimer:
Products information mentioned on this site is for informative purposes only. The product image belongs to the respective company. Genetec Lifesciences is a wholesaler and distributor, not a manufacturer. We source our medicines directly from the company or authorized vendors of the company.